Naureen Quibria
Stock Analyst at Capital One
(1.59)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BMEA Biomea Fusion | Initiates Coverage On: Overweight | 25 | 1.93 | 1195.34% | 1 | Aug 29, 2024 | |
IMMP Immutep | Initiates Coverage On: Overweight | 10 | 1.64 | 509.76% | 1 | May 17, 2024 | |
ERAS Erasca | Initiates Coverage On: Overweight | 8 | 1.56 | 412.82% | 1 | Mar 11, 2024 | |
CARM CARISMA Therapeutics | Initiates Coverage On: Overweight | 10 | n/a | n/a | 1 | Oct 3, 2023 | |
IMCR Immunocore Hldgs | Initiates Coverage On: Overweight | 84 | 35.24 | 138.37% | 1 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 40 | 7.12 | 461.8% | 1 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 11 | 8.76 | 25.57% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 7 | 8.54 | -18.03% | 2 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 21 | 2.95 | 611.86% | 1 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 22 | 0.53 | 4050.94% | 1 | Dec 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 900 | 8 | 11150% | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | n/a | n/a | 1 | Mar 16, 2021 |